Showing results (341-350 of 361) with videos related to

Sort By:
Pageof 37
Blood|January 1, 1980
Acute monoblastic leukemia: a clinical and biologic study of 74 casesG Tobelem, C Jacquillat, C Chastang, et al.
Bone Marrow Transplantation|August 24, 1999
Autologous stem cell transplantation in chronic myeloid leukemia: a single center experienceA Pigneux, C Faberes, J M Boiron, et al.
Bone Marrow Transplantation|May 1, 1996
High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemiaF X Mahon, C Fabères, M Montastruc, et al.
Blood|December 3, 1998
Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alphaF X Mahon, C Fabères, S Pueyo, et al.
Bone Marrow Transplantation|July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.
The Journal of Clinical Investigation|December 31, 1997
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral productsH Gahéry-Ségard, V Molinier-Frenkel, C Le Boulaire, et al.
Bone Marrow Transplantation|November 25, 1998
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experienceR M Lowenthal, C Fabères, G Marit, et al.
Leukemia|September 16, 1998
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric studyG Marit, F Thiessard, C Faberes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myelomaG Marit, C Faberes, J L Pico, et al.
Bulletin Du Cancer|May 1, 1996
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer]T Le Chevalier, D Brisgand, J L Pujol, et al.
Pageof 37